title: Is limited prehospital resuscitation with plasma more beneficial than using a synthetic colloid? An experimental study in rabbits with parenchymal bleeding.
abstract: BACKGROUND
  Reports of survival benefits of early transfusion of plasma with red blood cells (1:1 ratio) in trauma patients suggest that plasma may be a better fluid to replace Hextend for battlefield resuscitation. We studied possible advantages of prehospital resuscitation with plasma compared with Hextend or albumin in a model of uncontrolled hemorrhage.
  
  
  METHODS
  Male New Zealand white rabbits (3.3 ± 0.1 kg) were anesthetized, instrumented, and subjected to a splenic injury with uncontrolled bleeding. Ten minutes after injury (mean arterial pressure [MAP] < 40 mm Hg), the rabbits received small and equal volumes (15 mL/kg) of rabbit plasma (n = 10), Hextend (n = 10), or 5% human albumin (n = 9) or no fluid. Fluids were administered in two bolus injections (20 minutes apart) and targeted to a MAP of 65 mm Hg. Animals were monitored for 2.5 hours or until death, and their blood losses were measured. Arterial blood samples were collected at different times and analyzed for ABG, CBC, and coagulation tests.
  
  
  RESULTS
  There were no differences in baseline measures among groups. Splenic injury caused similar hemorrhages (9.1 ± 0.4 mL/kg at 10 minutes) and decreased MAP in all subjects. Subsequent resuscitation initiated additional bleeding. At 60 minutes after injury (20 minutes after resuscitation), longer activated partial thromboplastin time and lower fibrinogen concentrations were apparent compared with baseline values with differences among groups. Thrombelastography analysis indicated faster and stronger clot formation with plasma and albumin resuscitation than with Hextend use. Shock indices were increased in all groups, but smaller changes were measured in the albumin group. Total blood loss did not differ among resuscitated rabbits but was higher (p < 0.05) than among nonresuscitated animals. Survival rates were 11% (untreated), 40% (Hextend and plasma), and 89% (albumin, p < 0.05).
  
  
  CONCLUSIONS
  Resuscitation with plasma or albumin better preserved coagulation function than did Hextend. However, despite these improvements, plasma resuscitation did not reduce blood loss or improve survival, while albumin administration seemed beneficial.
authors: From the US Army Institute of Surgical Research, JBSA Fort Sam Houston, San Antonio, Texas.
authors: Bijan S
authors: BS
authors: Kheirabadi
authors: Krystal K
authors: KK
authors: Valdez-Delgado
authors: Irasema B
authors: IB
authors: Terrazas
authors: Nahir
authors: N
authors: Miranda
authors: Michael A
authors: MA
authors: Dubick
mesh_terms: D000418:Albumins / Q000494:pharmacology*; D000818:Animals; D003102:Colloids / Q000494:pharmacology*; D004632:Emergency Medical Services; D005440:Fluid Therapy / Q000379:methods*; D006470:Hemorrhage / Q000209:etiology / Q000628:therapy*; D006895:Hydroxyethyl Starch Derivatives / Q000494:pharmacology*; D008297:Male; D010314:Partial Thromboplastin Time; D010949:Plasma; D011817:Rabbits; D012151:Resuscitation / Q000379:methods*; D013154:Spleen / Q000293:injuries; D015996:Survival Rate
chemical_list: D000418:Albumins; D003102:Colloids; D006895:Hydroxyethyl Starch Derivatives